NCT07098663 - Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

January 19, 2026

Study Completion Date

April 17, 2026

Conditions

Type 2 Diabetes Mellitus (T2DM)Food EffectSafety and TolerabilityObesity

Interventions

DRUG

MKP10241

Oral liquid suspension of unit dose strength 6.6 mg/mL

DRUG

Placebo

Oral liquid suspension matched in appearance to MKP10241 at dosage strengths

Trial Locations (1)

RECRUITING

Veritus Research, Bayswater